F FANAPT ILOPERIDONE TABLETS

Serial Number 77694574
Registration 3800662
800

Registration Progress

Application Filed
Mar 19, 2009
Under Examination
Sep 29, 2009
Approved for Publication
Jun 17, 2009
Published for Opposition
Jul 7, 2009
Registered
Jun 8, 2010

Trademark Image

F FANAPT ILOPERIDONE TABLETS

Basic Information

Serial Number
77694574
Registration Number
3800662
Filing Date
March 19, 2009
Registration Date
June 8, 2010
Published for Opposition
July 7, 2009
Renewal Date
June 8, 2020
Drawing Code
3000

Status Summary

Current Status
Active
Status Code
800
Status Date
Dec 13, 2019
Registration
Registered
Classes
005

Rights Holder

Vanda Pharmaceuticals Inc.

03
Address
Suite 300E
2200 Pennsylvania Ave NW
Washington, DC 20037

Ownership History

Vanda Pharmaceuticals Inc.

Original Applicant
03
Rockville, MD

Vanda Pharmaceuticals Inc.

Owner at Publication
03
Rockville, MD

Vanda Pharmaceuticals Inc.

Original Registrant
03
Washington, DC

Legal Representation

Attorney
Jayme M. Torelli

USPTO Deadlines

Next Deadline
1609 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20100608)
Due Date
June 08, 2030
Grace Period Ends
December 08, 2030

Application History

38 events
Date Code Type Description Documents
Dec 13, 2019 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Loading...
Dec 13, 2019 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Loading...
Dec 13, 2019 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Dec 13, 2019 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Oct 30, 2019 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Jun 8, 2019 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Jun 10, 2016 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Jun 10, 2016 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Jun 10, 2016 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Mar 31, 2016 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Jun 8, 2010 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 4, 2010 SUNA O NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED Loading...
May 3, 2010 REGV O LAW OFFICE REGISTRATION REVIEW COMPLETED Loading...
May 3, 2010 ALIE A ASSIGNED TO LIE Loading...
Apr 22, 2010 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Apr 2, 2010 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED Loading...
Apr 1, 2010 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Mar 3, 2010 IUAF S USE AMENDMENT FILED Loading...
Apr 1, 2010 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 3, 2010 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 1, 2010 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Mar 3, 2010 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 3, 2010 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Sep 29, 2009 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 7, 2009 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 17, 2009 NPUB O NOTICE OF PUBLICATION Loading...
Jun 4, 2009 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Jun 4, 2009 ALIE A ASSIGNED TO LIE Loading...
Jun 2, 2009 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 2, 2009 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN Loading...
Jun 2, 2009 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 22, 2009 CNEA F EXAMINER'S AMENDMENT MAILED Loading...
May 22, 2009 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
May 22, 2009 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
May 15, 2009 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 24, 2009 MDSC O NOTICE OF DESIGN SEARCH CODE MAILED Loading...
Mar 23, 2009 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 23, 2009 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for use in the treatment of the central nervous system
First Use Anywhere: May 6, 2009
First Use in Commerce: Jan 11, 2010

Additional Information

Design Mark
The mark consists of stylized text reading "Fanapt" above stylized text reading "iloperidone tablets", with "iloperidone" appearing to the left of the descender in the "p" of "Fanapt", and "tablets" appearing to the right of the descender. All of the afore-described text appears below an approximately vertically rectangular shape with rounded corners which is bisected substantially horizontally by a stylized lower case letter "f".
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"ILOPERIDONE TABLETS"